Seeing Is Believing
Healthcare - Sector
Aerie Pharmaceuticals's activity chart (see below) currently has 192 price targets and 141 ratings on display.
Analysts average stock forecasts to be materialized ratio is 40.39% with an average time for these price targets to be met of 175.51 days.
Most recent stock forecast was given by from CITI on 29-Aug-2022. First documented stock forecast 19-Mar-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Dec-2019
$13
4 years 1 months 8 days ago
(29-Aug-2022)
1/6 (16.67%)
$4.7 (56.63%)
176
Buy Since 07-Nov-2019
$20
4 years 1 months 13 days ago
(24-Aug-2022)
0/5 (0%)
$14.21 (245.42%)
Buy Since 09-Jan-2020
$29
4 years 1 months 13 days ago
(24-Aug-2022)
0/2 (0%)
$14.55 (100.69%)
Buy Since 17-Sep-2015
$14
4 years 1 months 14 days ago
(23-Aug-2022)
7/19 (36.84%)
$7.75 (124.00%)
211
Buy Since 22-Oct-2019
$15.25
$62
4 years 1 months 14 days ago
(23-Aug-2022)
1/2 (50%)
$0.09 (0.59%)
48
What is AERI (Aerie Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on AERI (Aerie Pharmaceuticals)?
Which analyst has the most public recommendations on AERI (Aerie Pharmaceuticals)?
Which analyst is the currently most bullish on AERI (Aerie Pharmaceuticals)?
Which analyst is the currently most reserved on AERI (Aerie Pharmaceuticals)?